The methodological aspects, validations, and big sample sizes in both studies enforce the robustness of CRP/Alb as an easy prognostic indicator in hospitalized COVID-19 in terms of in-hospital complications and mortality, as well as post-admission mortality with a cutoff value indicating bad evolution of about 25 as a reasonable and operative proposal for clinical practice. The gene discussed is ALB; the disease is COVID-19.